PI 1a — 2016 — MARSEILLE Immunopole RESEARCH (Q3694464): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): The main challenge of Marseille Immunopôle is to make the metropolis Aix Marseille Provence, the European capital of immunological therapies R & D by strengthening the capacity of research centres and platforms to identify potential targets that could lead to further pharmaceutical developments, in the treatment of cancers and inflammatory diseases., translated_summary) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
PI 1a — 2016 — MARSEILLE Immunopole RESEARCH | |||
Revision as of 19:35, 18 November 2021
Project Q3694464 in France
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PI 1a — 2016 — MARSEILLE Immunopole RESEARCH |
Project Q3694464 in France |
Statements
1,151,148.18 Euro
0 references
3,873,981.05 Euro
0 references
29.71 percent
0 references
1 September 2015
0 references
31 December 2019
0 references
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM
0 references
L’enjeu principal de Marseille Immunopôle est de faire de la métropole Aix Marseille Provence, la capitale Européenne de la R&D de thérapies immunologiques en renforçant la capacité des centres de recherche et des plateformes à identifier des cibles potentielles pouvant mener à des développements pharmaceutiques ultérieurs, dans le traitement des cancers et maladies inflammatoires. (French)
0 references
The main challenge of Marseille Immunopôle is to make the metropolis Aix Marseille Provence, the European capital of immunological therapies R & D by strengthening the capacity of research centres and platforms to identify potential targets that could lead to further pharmaceutical developments, in the treatment of cancers and inflammatory diseases. (English)
18 November 2021
0 references
Identifiers
PA0005261
0 references